Literature DB >> 20673813

Role of CaMKII in cardiovascular health, disease, and arrhythmia.

Peter J Mohler1, Thomas J Hund.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20673813      PMCID： PMC2988944          DOI： 10.1016/j.hrthm.2010.07.029

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN： 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  9 in total

1.  L-type Ca2+ channel facilitation mediated by phosphorylation of the beta subunit by CaMKII.

Authors:  Chad E Grueter; Sunday A Abiria; Igor Dzhura; Yuejin Wu; Amy-Joan L Ham; Peter J Mohler; Mark E Anderson; Roger J Colbran
Journal:  Mol Cell       Date:  2006-09-01       Impact factor: 17.970

2.  Calmodulin kinase II inhibition shortens action potential duration by upregulation of K+ currents.

Authors:  Jingdong Li; Céline Marionneau; Rong Zhang; Vaibhavi Shah; Johannes W Hell; Jeanne M Nerbonne; Mark E Anderson
Journal:  Circ Res       Date:  2006-10-12       Impact factor: 17.367

3.  Calmodulin kinase II inhibition protects against structural heart disease.

Authors:  Rong Zhang; Michelle S C Khoo; Yuejin Wu; Yingbo Yang; Chad E Grueter; Gemin Ni; Edward E Price; William Thiel; Silvia Guatimosim; Long-Sheng Song; Ernest C Madu; Anisha N Shah; Tatiana A Vishnivetskaya; James B Atkinson; Vsevolod V Gurevich; Guy Salama; W J Lederer; Roger J Colbran; Mark E Anderson
Journal:  Nat Med       Date:  2005-03-27       Impact factor: 53.440

4.  Identification and expression of delta-isoforms of the multifunctional Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium.

Authors:  B Hoch; R Meyer; R Hetzer; E G Krause; P Karczewski
Journal:  Circ Res       Date:  1999-04-02       Impact factor: 17.367

5.  The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload.

Authors:  Johannes Backs; Thea Backs; Stefan Neef; Michael M Kreusser; Lorenz H Lehmann; David M Patrick; Chad E Grueter; Xiaoxia Qi; James A Richardson; Joseph A Hill; Hugo A Katus; Rhonda Bassel-Duby; Lars S Maier; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

6.  Cyclosporin and Timothy syndrome increase mode 2 gating of CaV1.2 calcium channels through aberrant phosphorylation of S6 helices.

Authors:  Christian Erxleben; Yanhong Liao; Saverio Gentile; David Chin; Claudio Gomez-Alegria; Yasuo Mori; Lutz Birnbaumer; David L Armstrong
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

7.  Calmodulin kinase II is required for fight or flight sinoatrial node physiology.

Authors:  Yuejin Wu; Zhan Gao; Biyi Chen; Olha M Koval; Madhu V Singh; Xiaoqun Guan; Thomas J Hund; William Kutschke; Satyam Sarma; Isabella M Grumbach; Xander H T Wehrens; Peter J Mohler; Long-Sheng Song; Mark E Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-10       Impact factor: 11.205

8.  Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.

Authors:  Haiyun Ling; Tong Zhang; Laetitia Pereira; Christopher Kable Means; Hongqiang Cheng; Yusu Gu; Nancy D Dalton; Kirk L Peterson; Ju Chen; Donald Bers; Joan Heller Brown; Joan Heller Brown
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

9.  Ca/calmodulin kinase II differentially modulates potassium currents.

Authors:  Stefan Wagner; Elena Hacker; Eleonora Grandi; Sarah L Weber; Nataliya Dybkova; Samuel Sossalla; Thomas Sowa; Larissa Fabritz; Paulus Kirchhof; Donald M Bers; Lars S Maier
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-04-17
  9 in total
  8 in total

1.  Integrative functional analysis of super enhancer SNPs for coronary artery disease.

Authors:  Juexiao Gong; Chuan Qiu; Dan Huang; Yiyan Zhang; Shengyong Yu; Chunping Zeng
Journal:  J Hum Genet       Date:  2018-02-28       Impact factor: 3.172

Review 2.  Computational approaches to understand cardiac electrophysiology and arrhythmias.

Authors:  Byron N Roberts; Pei-Chi Yang; Steven B Behrens; Jonathan D Moreno; Colleen E Clancy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-10       Impact factor: 4.733

3.  Polybrominated diphenyl ether (PBDE) exposure in children: possible associations with cardiovascular and psychological functions.

Authors:  Brooks B Gump; Sehun Yun; Kurunthachalam Kannan
Journal:  Environ Res       Date:  2014-05-13       Impact factor: 6.498

4.  Role of CaMKII and PKA in Early Afterdepolarization of Human Ventricular Myocardium Cell: A Computational Model Study.

Authors:  Ling Dai; Yunliang Zang; Dingchang Zheng; Ling Xia; Yinglan Gong
Journal:  Comput Math Methods Med       Date:  2016-12-08       Impact factor: 2.238

5.  Identification of Four Potential Biomarkers Associated With Coronary Artery Disease in Non-diabetic Patients by Gene Co-expression Network Analysis.

Authors:  Min Jiao; Jingtian Li; Quan Zhang; Xiufeng Xu; Ruidong Li; Peikang Dong; Chun Meng; Yi Li; Lijuan Wang; Wanpeng Qi; Kai Kang; Hongjie Wang; Tao Wang
Journal:  Front Genet       Date:  2020-06-24       Impact factor: 4.599

6.  CaMKII orchestrates endoplasmic reticulum stress and apoptosis in doxorubicin-induced cardiotoxicity by regulating the IRE1α/XBP1s pathway.

Authors:  Lingheng Kong; Yimeng Zhang; Jiayi Ning; Chennian Xu; Zhenyi Wang; Jian Yang; Lifang Yang
Journal:  J Cell Mol Med       Date:  2022-09-16       Impact factor: 5.295

7.  Activation of Orexin System Stimulates CaMKII Expression.

Authors:  Yuanyuan Fan; Enshe Jiang; Huanjia Gao; Jeremy Bigalke; Bojun Chen; Chunxiu Yu; Qinghui Chen; Zhiying Shan
Journal:  Front Physiol       Date:  2021-07-01       Impact factor: 4.566

8.  Tilianin Protects against Ischemia/Reperfusion-Induced Myocardial Injury through the Inhibition of the Ca2+/Calmodulin-Dependent Protein Kinase II-Dependent Apoptotic and Inflammatory Signaling Pathways.

Authors:  Hailun Jiang; Jianguo Xing; Jiansong Fang; Linlin Wang; Yu Wang; Li Zeng; Zhuorong Li; Rui Liu
Journal:  Biomed Res Int       Date:  2020-10-09       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.